Where does attention-deficit/hyperactivity disorder fit in the psychopathology hierarchy? A symptom-focused analysis
- PMID: 39679963
- PMCID: PMC12226816
- DOI: 10.1037/abn0000966
Where does attention-deficit/hyperactivity disorder fit in the psychopathology hierarchy? A symptom-focused analysis
Abstract
Modern psychopathology classification systems position attention-deficit/hyperactivity disorder (ADHD) with different groups of conditions, either with externalizing or neurodevelopmental. As such, the optimal placement of ADHD in modern classification systems remains unclear. We advanced the literature by mapping ADHD symptoms onto three transdiagnostic psychopathology spectra-externalizing, neurodevelopmental, and internalizing-and their symptoms. ADHD symptoms had varied associations with different spectra, with subsets of symptoms relating most strongly to externalizing, others to neurodevelopmental, and still others to internalizing. Impulsivity, poor schoolwork, and low perseverance were most closely tied to externalizing, cognitive disengagement symptoms (e.g., confused, stared blankly, daydreamed) and immaturity were most closely tied to neurodevelopment, and cognitive disengagement symptoms were also tied to internalizing. Our findings advise against conceptualizing and treating ADHD as a unitary construct and against placing ADHD exclusively under either externalizing or neurodevelopmental spectra. Symptom-focused approaches will better inform modern psychopathology classification systems. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
Conflict of interest statement
Conflicts of Interest
There is no conflict of interest in authorship or the publication of this article.
Similar articles
-
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161373 Free PMC article.
-
Methylphenidate for children and adolescents with autism spectrum disorder.Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2. Cochrane Database Syst Rev. 2017. PMID: 29159857 Free PMC article.
-
Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2018 Mar 23;3(3):CD010840. doi: 10.1002/14651858.CD010840.pub2. Cochrane Database Syst Rev. 2018. PMID: 29566425 Free PMC article.
-
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.Cochrane Database Syst Rev. 2016 Feb 4;2(2):CD009996. doi: 10.1002/14651858.CD009996.pub2. Cochrane Database Syst Rev. 2016. PMID: 26844979 Free PMC article.
-
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2. Cochrane Database Syst Rev. 2017. PMID: 28965364 Free PMC article.
Cited by
-
Cognitive disengagement syndrome: A construct at the crossroads.Am Psychol. 2025 Jul-Aug;80(5):812-834. doi: 10.1037/amp0001517. Epub 2025 Mar 27. Am Psychol. 2025. PMID: 40146579 Review.
References
-
- American Psychiatric Association (Ed.). (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed). American Psychiatric Association. 10.1176/appi.books.9780890425596 - DOI
-
- Andrews G, Pine DS, Hobbs MJ, Anderson TM, & Sunderland M. (2009). Neurodevelopmental disorders: Cluster 2 of the proposed meta-structure for DSM-V and ICD-11: Paper 3 of 7 of the thematic section: ‘A proposal for a meta-structure for DSM-V and ICD-11.’ Psychological Medicine, 39(12), 2013–2023. 10.1017/S0033291709990274 - DOI - PMC - PubMed
-
- Bauermeister JJ, Alegría M, Bird HR, Rubio-stipec M, & Canino G. (1992). Are attentional-hyperactivity deficits unidimensional or multidimensional syndromes? Empirical findings from a community survey. Journal of the American Academy of Child & Adolescent Psychiatry, 31(3), 423–431. 10.1097/00004583-199205000-00007 - DOI - PubMed
Grants and funding
- R00 AA028306/AA/NIAAA NIH HHS/United States
- U24 DA041147/DA/NIDA NIH HHS/United States
- U01 DA051039/DA/NIDA NIH HHS/United States
- U01 DA041120/DA/NIDA NIH HHS/United States
- U01 DA051018/DA/NIDA NIH HHS/United States
- U01 DA041093/DA/NIDA NIH HHS/United States
- U24 DA041123/DA/NIDA NIH HHS/United States
- U01 DA051038/DA/NIDA NIH HHS/United States
- U01 DA051037/DA/NIDA NIH HHS/United States
- U01 DA051016/DA/NIDA NIH HHS/United States
- U01 DA041106/DA/NIDA NIH HHS/United States
- U01 DA041117/DA/NIDA NIH HHS/United States
- U01 DA041148/DA/NIDA NIH HHS/United States
- U01 DA041174/DA/NIDA NIH HHS/United States
- U01 DA041134/DA/NIDA NIH HHS/United States
- U01 DA041022/DA/NIDA NIH HHS/United States
- U01 DA041156/DA/NIDA NIH HHS/United States
- U01 DA050987/DA/NIDA NIH HHS/United States
- U01 DA041025/DA/NIDA NIH HHS/United States
- U01 DA050989/DA/NIDA NIH HHS/United States
- U01 DA041089/DA/NIDA NIH HHS/United States
- U01 DA050988/DA/NIDA NIH HHS/United States
- NH/NIH HHS/United States
- U01 DA041028/DA/NIDA NIH HHS/United States
- U01 DA041048/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials